Work

Correlation of receptor activator of nuclear factor kappa b (RANK) expression in breast cancer (BC) at the time of diagnosis with recurrence-free survival (RFS) and risk of bone-dominant metastases (BDM) in the I-SPY 1 trial (CALGB 150007/150012; ACRIN 6657).

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.27_suppl.2

Authors: Jiali Li, Christina Yau, Michael Campbell, Laura Esserman, John W. Park, Hope S. Rugo, CALGB 150007/150012; ACRIN 6657

Institutions: University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, Buck Institute for Research on Aging

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2272569805

Cites:

Cited by: 3

Related to: 10